Litigation Details for Mary Jane Jasin v. Vivus, Inc. (N.D. Cal. 2014)
✉ Email this page to a colleague
Mary Jane Jasin v. Vivus, Inc. (N.D. Cal. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-07-18 |
Court | District Court, N.D. California | Date Terminated | 2016-04-19 |
Cause | 15:78m(a) Securities Exchange Act | Assigned To | Beth Labson Freeman |
Jury Demand | Plaintiff | Referred To | Howard R Lloyd |
Patents | 6,071,537 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Mary Jane Jasin v. Vivus, Inc.
Details for Mary Jane Jasin v. Vivus, Inc. (N.D. Cal. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-06-18 | 31 | 9 obesity,” and the “Shank Patent,” U.S. Patent No. 6,071,537, which was held by Johnson & … 7 1999 patent filed by Dr. Susan McElroy, the “McElroy Patent,” U.S. Patent No. 6,323,236, … 6 other patents which they contend posed risks to the Najarian Patent: an earlier filed February…an August 25, 2014 transfer of the patent to Vivus, which patented topiramate alone … all related patent applications, 16 or the Patents, were transferred | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |